Skip to main content

Advertisement

Table 1 Baseline Demographic and Clinical Data

From: Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases

  all cases with renal biopsy without renal biopsy P value
no. of case 102 43 59  
sex (M:F) 46: 56 17: 26 29: 30 p = 0.4b
age (years) 55.07 ± 14.99 55.43 ± 14.87 54.81 ± 15.19 p = 0.8a
blood pressure (mmHg)     
 systolic 151.3 ± 47.0 144.0 ± 19.2 156.7 ± 59.2 p = 0.2a
 diastolic 78.5 ± 13.4 77.7 ± 12.7 79.2 ± 13.9 p = 0.6a
serum creatinine (μmol/l) 203.50 (98.25–387.75) 127.00 (69.50–283.00) 242.00 (116.00–473.50) p = 0.011c
estimated GFR (ml/min/1.73m2) 44.27 ± 42.63 53.49 ± 39.90 37.55 ± 43.62 p = 0.06a
proteinuria (g/day) 1.11 (0.33–2.44) 1.21 (0.61–2.32) 1.03 (0.28–2.45) p = 0.6c
urinary mtDNA 1519.42 (511.81–3073.03) 1825.33 (753.63–6749.94) 1207.37 (499.45–2319.48) p = 0.047c
  1. GFR glomerular filtration rate, mtDNA mitochondrial DNA (expressed as million copy per mmol creatinine in urine)
  2. Data are expressed as mean ± standard deviation or median (inter-quartile range [IQR]), and compared by aStudent’s t test, bChi-square test, or cMann-Whitney U test